Upcoming Webinars Archived Webinars Training Vitals Host A Webinar About Get Updates Contact

Xtalks Vitals Pharmaceutical Marketing News

Pharmaceutical Biotech Medical Device Food Clinical Trials Drug Safety Pharmaceutical Marketing Life Science
FEATURED

Use of Testosterone Treatments Boosted by DTC Ad Campaigns

March 24, 2017

Those with a stake in the pharmaceutical industry often question the effectiveness of direct-to-consumer (DTC) advertising, and whether it truly influences consumers to talk to their doctors about medical conditions and perhaps even ask for drugs by name.

Featured In: Pharmaceutical Marketing News

THE LATEST
Allergan’s Dry Eye Ad Campaign Aims to Raise Disease Awareness

March 14, 2017 - Using its new ad campaign titled, “Eyepowerment,” global pharmaceutical company Allergan hopes to inspire individuals experiencing these symptoms to talk to their doctor about treatment options for the eye condition.

Featured In: Pharmaceutical Marketing News


Controversial List Price Puts Muscular Dystrophy Drug Launch on Hold

February 15, 2017 - Though rebates and financial assistance promised by Marathon could bring the cost of the medication down to $54,000 per year, this is much more expensive than some patients were originally paying.

Featured In: Pharmaceutical Marketing News



Gilead Diversifies Pharmaceutical Marketing Strategy for HIV Drug

February 14, 2017 - According to an article published in MM&M, biopharma company Gilead Sciences will use some unconventional platforms – including Tumblr, Snapchat and dating sites – as part of their pharmaceutical marketing strategy for their HIV preventative treatment, Truvada.

Featured In: Pharmaceutical Marketing News


Amgen’s Humira Biosimilar Recommended for EMA Approval

February 1, 2017 - An advisory committee to the European Medicines Agency (EMA) recently recommended the approval of Amgen’s biosimilar of AbbVie’s Humira.

Featured In: Pharmaceutical Marketing News

WATCH & PARTICIPATE IN THESE WEBINARS 


How to Improve the Speed and Efficiency of Your Clinical Trials

High Performance Computing for High Content Screening - A Case Study


AstraZeneca’s Asthma Drug Receives Expanded Indication from FDA

January 31, 2017 - The US Food and Drug Administration (FDA) has approved AstraZeneca’s Symbicort (budesonide/formoterol fumarate dihydrate) for control of asthma in pediatric patients aged six to 12.

Featured In: Pharmaceutical Marketing News


Kaléo Pharma’s EpiPen Alternative Launched with Expensive List Price

January 30, 2017 - Much to the dismay of insurers and pharmacy benefit managers, Kaléo Pharma has announced that the list price for a two-pack of its EpiPen alternative auto-injectors will be set at $4,500.

Featured In: Medical Device News, Pharmaceutical Marketing News


PhRMA Launches New Ad Campaign to Improve Biopharma’s Image

January 26, 2017 - Pharmaceutical industry trade group, PhRMA, has unveiled a new multimillion-dollar ad campaign named GoBoldly.

Featured In: Pharmaceutical Marketing News


FDA Guidance on Biosimilar Naming to Support Pharmacovigilance

January 16, 2017 - After much speculation and debate, the US Food and Drug Administration (FDA) has released guidance for biologic and biosimilar product naming conventions.

Featured In: Pharmaceutical Marketing News, Biotech News


Pfizer Launches App for Patients with Depression

December 20, 2016 - Drugmakers are gradually breaking into the popular health app space, with big pharmaceutical company, Pfizer, launching its mood tracking app for people with depression.

Featured In: Pharmaceutical Marketing News


Mylan Launches Generic EpiPen Priced at $300 for a Two-Pack

December 19, 2016 - In an attempt to quell some of the drug pricing outrage that has surrounded the EpiPen, Mylan has released the first authorized generic of the device, priced at $300 for a two-pack of epinephrine injectors.

Featured In: Pharmaceutical Marketing News


Pfizer’s Eczema Drug Gains FDA Approval

December 16, 2016 - The US Food and Drug Administration (FDA) has approved Pfizer’s Eucrisa (crisaborole), a novel treatment for mild to moderate atopic dermatitis – also known as eczema.

Featured In: Pharmaceutical Marketing News


FDA Finds Sanofi and Celgene DTC Ads are Misleading

December 16, 2016 - The US Food and Drug Administration (FDA) has identified two direct-to-consumer (DTC) ads for prescription drugs, which it believes misleads consumers in regards to the safety of the medications.

Featured In: Pharmaceutical Marketing News


FDA Approves Jardiance for Patients with Type 2 Diabetes and Cardiovascular Disease

December 6, 2016 - The drug can now be prescribed to reduce the risk of cardiovascular death, due to events like heart attack and stroke, in patients with type 2 diabetes.

Featured In: Pharmaceutical Marketing News


Synthetic Human Tissue to Advance Personalized Medicine

December 1, 2016 - The technique could help researchers understand why some drugs are effective in some, but not in others, to drive drug innovation and improvement for more personalized treatments.

Featured In: Pharmaceutical Marketing News


How Will the Trump Presidency Affect Pharmaceutical Marketing?

November 30, 2016 - Donald Trump’s election win could have significant effects on the pharmaceutical industry, but whether these changes will be good or bad has yet to be seen.

Featured In: Pharmaceutical Marketing News


FDA Looks Into Social Media Marketing of Drugs

November 11, 2016 - The US Food and Drug Administration (FDA) requires pharmaceutical marketers to mention both the benefits and the risks of a given drug in direct-to-consumer advertisements and other types of promotion.

Featured In: Pharmaceutical Marketing News


EpiPen Alternative Could Hit Pharmacy Shelves Next Year

October 27, 2016 - While Mylan’s controversial EpiPen currently holds significant market share, the medical device is about to face some stiff competition.

Featured In: Pharmaceutical Marketing News, Medical Device News


Doctors Should Push HPV Vaccine for Cancer Prevention, Says CDC

October 21, 2016 - To increase the number of kids getting vaccinated against Human Papilloma Virus (HPV), the Centers For Disease Control and Prevention (CDC) is encouraging doctors to emphasize the shot as a form of cancer prevention, rather than STD protection.

Featured In: Pharmaceutical Marketing News


Study Finds Most People Don’t Read Pharmaceutical Risk Disclosures

October 20, 2016 - Despite the fact that consumers claim to read the risk disclosures on websites for branded pharmaceuticals, research conducted at the University of Tennessee suggests that this isn’t always true.

Featured In: Pharmaceutical Marketing News


US Hospitals Also Affected By High Drug Costs

October 14, 2016 - Hospitals have now joined consumer groups and health insurance companies in urging the US government to take a stand on prescription drug pricing.

Featured In: Pharmaceutical Marketing News


Quadrivalent Influenza Vaccine Gains FDA Approval

October 13, 2016 - This latest version of the influenza vaccine protects against three of the same strains found in the previous trivalent Flublok, in addition to a fourth B strain of the virus.

Featured In: Pharmaceutical Marketing News


Amgen’s Humira Biosimilar Gets FDA Green Light

September 27, 2016 - In a major win for Amgen, the US Food and Drug Administration (FDA) has approved Amjevita (adalimumab-atto), a biosimilar of AbbVie’s Humira (adalimumab).

Featured In: Pharmaceutical Marketing News, Biotech News


Amid Controversy, Duchenne Muscular Dystrophy Drug Is Approved By FDA

September 20, 2016 - Benefitting from an accelerated approval, Sarepta Therapeutics’ Exondys 51 is the first drug to become available to patients with the disease.

Featured In: Pharmaceutical Marketing News


The Battle of the Biologics and Biosimilars Continues

September 12, 2016 - A major patent on Humira® may expire December 2016 and there is much debate over its renewal by the patent trial and appeal board.

Featured In: Pharmaceutical Marketing News


Mandatory HPV Vaccination Should Be Paired With Opt-Out Option, Says Study

September 8, 2016 - There are currently two vaccines available – Merck’s Gardasil and GlaxoSmithKline’s Cervarix – which protect against the most common strains of the virus.

Featured In: Pharmaceutical Marketing News


New Study Suggests Strategies To Deal With High Cost Of Prescription Drugs

August 25, 2016 - A recent study published in The Journal of the American Medical Association, has examined the multiple factors that contribute to the high cost of prescription pharmaceuticals in the US, including the granting of government-protected monopolies and the constraints on price negotiations.

Featured In: Pharmaceutical Marketing News


FDA Grants Fast Track To Eli Lilly And AstraZeneca’s Alzheimer’s Drug

August 24, 2016 - The drug – developed by Eli Lilly and AstraZeneca – is a beta secretase cleaving enzyme (BACE) inhibitor that is currently being assessed in Phase III clinical trials.

Featured In: Pharmaceutical Marketing News, Clinical Trials News


Heron Gains FDA Approval For Antinausea Drug For Chemotherapy Patients

August 12, 2016 - After a nearly six year regulatory approval process, Heron Therapeutics has finally received US Food and Drug Administration (FDA) approval for its long-acting antinausea drug, Sustol.

Featured In: Pharmaceutical Marketing News


Novartis’ Breast Cancer Drug Receives FDA Breakthrough Therapy Designation

August 4, 2016 - Pharmaceutical company Novartis has received a coveted US Food and Drug Administration (FDA) breakthrough therapy designation for its breast cancer drug, LEE011 (ribociclib).

Featured In: Pharmaceutical Marketing News


Sanofi’s Once-Daily Diabetes Drug Wins FDA Approval

July 29, 2016 - The US Food and Drug Administration (FDA) has approved Sanofi’s once-daily diabetes drug, Adlyxin (lixisenatide).

Featured In: Pharmaceutical Marketing News


Update: FDA Panel Supports Approval Of Valeant’s Psoriasis Drug With Risk Management

July 21, 2016 - While the FDA has not officially approved the drug, the agency usually follows the advice of the advisory panel.

Featured In: Pharmaceutical Marketing News, Drug Safety News


Shire Receives Long-Awaited Approval For Dry Eye Drug

July 13, 2016 - Almost one year after being rejected by the US Food and Drug Administration (FDA), Shire’s dry eye disease drug, lifitegrast, has finallyreceived regulatory approval.

Featured In: Pharmaceutical Marketing News


Federal Appeals Court Upholds Biosimilar Marketing Rules

July 7, 2016 - Biosimilar drugmakers are required by law to give brand-name pharmaceutical companies six months’ notice before launching their copy on the market, ruled a federal appeals court.

Featured In: Pharmaceutical Marketing News, Biotech News


Roche300 photo Roche300 1_zpslgzsf7qr.jpg FDA Grants Priority Review To Roche’s Multiple Sclerosis Drug

June 29, 2016 - The decision could lead to accelerated approval of the drug, which means the biologic could hit the market by the end of 2016.

Featured In: Pharmaceutical Marketing News


Amgen and Sandoz Still In Legal Battle Over Biosimilar Marketing

June 24, 2016 - The point up for debate is whether Sandoz should be able to market their drug, Zarxio, which is a biosimilar version of Amgen’s Neulasta.

Featured In: Pharmaceutical Marketing News


First Single-Dose Cholera Vaccine Approved By FDA

June 15, 2016 - The vaccine is designed to protect against cholera infection and is the world’s first single-dose preventative treatment.

Featured In: Pharmaceutical Marketing News, Life Science News, Biotech News


Load More News


Roche’s Home Healthcare Medical Device For Anticoagulant Therapy Launches In Europe

June 2, 2016 - Roche has launched a new PT/INR home self-testing device for European patients taking anticoagulant drugs.

Featured In: Pharmaceutical Marketing News


FDA Approves First Medical Device Implant For Opioid Dependence

May 31, 2016 - The US Food and Drug Administration (FDA) has approved the first buprenorphine implantable medical device – marketed as Probuphine - for patients with opioid dependence.

Featured In: Pharmaceutical Marketing News


Roche’s Immunotherapy Drug Wins FDA Approval

May 20, 2016 - Roche’s anti-PDL1 immunotherapy, atezolizumab, has become the first new drug in decades to be approved to treat the most common form of bladder cancer.


UPDATE: Valeant Releases Details On Hospital Discount Plan For Heart Drugs

May 18, 2016 - Amid criticism over Valeant’s failure to deliver on promised hospital discounts for two of their heart drugs, the company has released the details of its rebate program for Isuprel and Nitropress.


Vermont Wants Drugmakers To Be Held Accountable For Pharmaceutical Price Increases

May 17, 2016 - In Vermont, a new bill is on the table which could require pharmaceutical companies to explain their reasoning behind price increases of prescription drugs.


Hospitals Still Waiting On Promised Discounts For Valeant’s Heart Drugs

May 16, 2016 - Early this year, Valeant Pharmaceuticals pledged to offer hospitals up to 30 percent off the list price for their expensive heart medications.


Cigna Makes Pricing Deals With Amgen, Sanofi For Cholesterol Drugs

May 13, 2016 - Cigna, a major US health insurer, has signed value-based pricing deals with the makers of two new PCSK9 cholesterol lowering drugs, Amgen and Sanofi.


First Drug To Treat Parkinson’s Disease Psychosis Approved By The FDA

May 3, 2016 - A drug made by California-based biopharmaceutical company Acadia Pharmaceuticals, has become the first US Food and Drug Administration (FDA) approved treatment for psychosis linked to Parkinson’s disease.


Injectable Multiple Sclerosis Drug Passes EMA Regulatory Review

May 3, 2016 - The European Medicines Agency (EMA) has recommended Biogen and AbbVie’s injectable multiple sclerosis drug for marketing approval.


Patient Advocacy Group Calls On Congress To Investigate FDA’s Role In Essure Approval

May 2, 2016 - A women’s advocacy group for patients who experienced adverse reactions associated with Bayer’s contraceptive implant, Essure, have criticized the US Food and Drug Administration (FDA) for its alleged lack of oversight for the medical device.


Survey Finds DTC Ads Have Little Influence Over Consumer Behaviour

April 22, 2016 - According to a survey conducted by market research firm Treato, only 7 percent of consumers reported talking to their doctor about a drug they saw advertised on TV.


FDA Approves AbbVie’s Drug For Rare Leukemia

April 13, 2016 - The US Food and Drug Administration (FDA) has approved AbbVie’s Venclexta as a second-line treatment for chronic lymphocytic leukemia, in patients with a chromosomal abnormality known as a 17p deletion.


FDA Approves Celltrion’s Remicade Biosimilar

April 11, 2016 - Celltrion’s Inflectra – a biosimilar to Janssen Biotech’s Remicade – is the second biosimilar to be approved by the US Food and Drug Administration (FDA).


FDA Approves Gilead’s HIV Therapy, Descovy

April 6, 2016 - Descovy is to be used in combination with other antiretroviral drugs, but is not indicated for use as a prophylactic to reduce the risk of HIV infection.


EMA Approves First Gene Therapy For Pediatric Rare Disease

April 5, 2016 - A new gene therapy developed by GlaxoSmithKline has been approved by the European Medicines Agency (EMA) for use in children with the ultra-rare genetic disease, adenosine deaminase severe combined immune deficiency (ADA-SCID).


Jazz Pharmaceuticals Wins FDA Approval For Rare Liver Disease Drug

April 1, 2016 - At long last, Jazz Pharmaceuticals has received US Food and Drug Administration (FDA) approval for its rare liver disease drug, defibrotide.


Anthem Files Lawsuit Against Express Scripts Over Drug Pricing Dispute

March 23, 2016 - On Monday, health insurance company Anthem Inc. filed a lawsuit against their pharmacy benefit manager, Express Scripts, to reportedly recover damages due to pharmaceutical pricing and operations issues.


FDA Mandates Addition Of Black Box Warning On Bayer’s Essure Permanent Birth Control

March 4, 2016 - In an effort to ensure physicians and patients are aware of the potential complications of using Bayer’s Essure – an implantable form of permanent birth control – the US Food and Drug Administration (FDA) is calling for a change in the product’s labelling.


Doctors Criticize Otsuka Pharmaceutical For Price Of Tuberculosis Drug

March 1, 2016 - Humanitarian group Doctors Without Borders, has publicly condemned Japanese drugmaker Otsuka Pharmaceutical for the “ridiculously high” cost of their relatively-new tuberculosis (TB) drug.


LinkedIn May See Increased Use Among Pharma Marketers Thanks To InMail Function

February 12, 2016 - LinkedIn is emerging as a favourite among pharma professionals due in part to the site’s sponsored InMail function.


The Surprising Link Between Vaccine Shortages And Price Per Dose

February 11, 2016- Using research into the economics of vaccine availability over the past 10 years, Ridley found that each 10 percent increase in the price of vaccines was linked with a one percent decrease in the probability of a shortage.


FDA: Celltrion’s Remicade Biosimilar “Highly Similar” To Branded Drug

February 9, 2016 - According to US Food and Drug Administration (FDA) documents, the agency is in favour of Celltrion’s biosimilar of Johnson & Johnson’s Remicade.


UK Cost Agency Backs Seven Biologics For Rheumatoid Arthritis

January 28, 2016 - The National Institute for Heath and Care Excellence (NICE) – a UK cost-effectiveness agency – is backing seven biological disease modifying drugs designed to treat severe rheumatoid arthritis.


Double Approval For Amgen’s Kyprolis and Repatha

January 27, 2016 - Amgen has started 2016 on a strong note, with two regulatory approvals for the company’s drugs Kyprolis and Repatha.


Shkreli and Schiller To Testify At Congressional Hearing On Drug Pricing

January 22, 2016 - Former Turing Pharma CEO Martin Shkreli, and Valeant Pharmaceutical’s interim CEO Howard Schiller are expected to participate in a Congressional hearing on pharmaceutical pricing set for January 26.


Sanofi To Cease Marketing Of MannKind’s Inhaled Insulin, Afrezza

January 7, 2016 - The company says the decision was made based on the lackluster number of prescriptions for Afrezza, despite launching a targeted “Surprise, it’s insulin” campaign in 2015, along with additional investments in marketing.


American Association Of Advertising Agencies To Lobby Against Proposed DTC Ad Ban

January 7, 2016 - The advertising trade group known as the American Association of Advertising Agencies (4A’s) published an op-ed piece on PharmExec.com on Monday promising to defend the industry’s right to use direct-to-consumer (DTC) ads for pharmaceuticals and medical devices.


 
Copyright © 2016-2017 Honeycomb Worldwide Inc.